MT-ND4 — NADH:Ubiquinone Oxidoreductase Core Subunit 4

Illustration of the eye cross-section showing the retina at the back of the eye

The MT-ND4 gene contains the instructions for making a protein that is a crucial part of your mitochondria, the 'powerhouses' of your cells. This protein helps form a large machine called Complex I, which is responsible for the first step in converting the food you eat into the energy your cells need to survive and function properly. When there is a mutation in the MT-ND4 gene, this energy-producing machine doesn't work correctly. This can lead to a shortage of energy in cells and an increase in harmful molecules called reactive oxygen species. The cells in the optic nerve, which carry visual information from your eyes to your brain, are particularly sensitive to these energy shortages and damage. As a result, these cells can die, leading to sudden and severe vision loss, which is the hallmark of a condition called Leber hereditary optic neuropathy (LHON).

Gene description: The MT-ND4 gene provides instructions for making a protein called NADH dehydrogenase 4, which is a core subunit of the mitochondrial complex I. This enzyme complex is essential for oxidative phosphorylation, the process that converts energy from food into ATP. Mutations in MT-ND4 impair mitochondrial respiration and are a primary cause of inherited mitochondrial diseases.

Patient and family guide: The MT-ND4 gene contains the instructions for making a protein that is a crucial part of your mitochondria, the 'powerhouses' of your cells. This protein helps form a large machine called Complex I, which is responsible for the first step in converting the food you eat into the energy your cells need to survive and function properly. When there is a mutation in the MT-ND4 gene, this energy-producing machine doesn't work correctly. This can lead to a shortage of energy in cells and an increase in harmful molecules called reactive oxygen species. The cells in the optic nerve, which carry visual information from your eyes to your brain, are particularly sensitive to these energy shortages and damage. As a result, these cells can die, leading to sudden and severe vision loss, which is the hallmark of a condition called Leber hereditary optic neuropathy (LHON).

Gene function: NADH dehydrogenase 4 is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q10) in the first step of the mitochondrial electron transport chain, which is coupled to the pumping of protons across the inner mitochondrial membrane to drive ATP synthesis.

Protein structure: The MT-ND4 protein is a 52 kDa highly hydrophobic protein composed of 459 amino acids. It forms a long, hydrophobic transmembrane domain that is a core component of the transmembrane region of Complex I.

Molecular function: MT-ND4 functions as a core subunit of the respiratory chain Complex I (NADH:ubiquinone oxidoreductase). It is essential for the catalytic activity of NADH dehydrogenation and the subsequent electron transfer to ubiquinone (coenzyme Q10). The flow of electrons through Complex I changes the redox state of the protein, resulting in a conformational change that pumps hydrogen ions (protons) out of the mitochondrial matrix across the inner mitochondrial membrane. This creates an electrochemical gradient (proton motive force) that is utilized by ATP synthase to generate ATP.

Mutation spectrum: The mutation spectrum of MT-ND4 primarily consists of missense mutations (single nucleotide polymorphisms). The most common and well-known mutation is m.11778G>A (Arg340His), which accounts for the majority of Leber hereditary optic neuropathy (LHON) cases. Other notable missense mutations include m.11696G>A and m.11253T>C. A mutation associated with Leigh syndrome is m.11777C>A (Arg340Ser).

Clinical significance: Mutations in the MT-ND4 gene disrupt the normal function of mitochondrial Complex I, leading to impaired electron transport and decreased ATP production. This energy deficit, often accompanied by increased oxidative stress from reactive oxygen species, primarily affects tissues with high energy demands. The most common clinical manifestation is Leber hereditary optic neuropathy (LHON), characterized by bilateral, painless, subacute visual failure due to the degeneration of retinal ganglion cells and the optic nerve. Less frequently, mutations can cause Leigh syndrome, a severe progressive neurodegenerative disorder.

Inheritance: Mitochondrial

Chromosomal location: mitochondrial

Research and therapeutic approaches: A major therapeutic approach targeting MT-ND4 mutations is gene therapy, specifically allotopic expression. Lenadogene nolparvovec (GS010 or NR082) is an investigational gene therapy that uses a recombinant adeno-associated virus vector (rAAV2/2-ND4) to deliver a functional copy of the MT-ND4 gene to retinal ganglion cells via intravitreal injection. Clinical trials (e.g., the REFLECT and GOLD trials) have shown promising results in improving visual acuity in LHON patients with the m.11778G>A mutation. Other approaches include the use of idebenone, an antioxidant that can bypass Complex I to transfer electrons directly to Complex III.